...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Unveiling the Vasodilatory Actions and Mechanisms of Relaxin
【24h】

Unveiling the Vasodilatory Actions and Mechanisms of Relaxin

机译:揭示松弛素的血管舒张作用和机制

获取原文

摘要

Relaxin is a 6-kDa peptide hormone that is secreted from the corpus luteum of the ovary and circulates in the blood during pregnancy in several species, including humans, rats, and mice1 (see Appendix for relaxin ligand and receptor nomenclature). Hisaw and colleagues,2,3? who discovered the hormone, provided the first evidence, albeit structural in nature, that the vasculature is a relaxin target. In ovariectomized monkeys administered relaxin, they noted marked morphological changes in the endothelial cells of endometrial blood vessels consistent with hypertrophy and hyperplasia, as well as enlargement of arterioles and capillaries.4,5?Functional evidence for a vasodilatory role of the hormone was initially reported by St-Louis and Massicotte,6 who demonstrated that chronic infusion of purified rat or porcine relaxin decreased systolic blood pressure in female spontaneously hypertensive rats but not Wistar-Kyoto rats. In another study, the same group of investigators showed that short-term administration of purified rat relaxin decreased mean arterial pressure in female spontaneously hypertensive rats as early as 8 hours after initiating the infusion, and the vasoconstrictor responses to norepinephrine and arginine vasopressin were blunted in the mesenteric circulation of these animals perfused in situ.7 Subsequently, some doubt about the physiological importance of the vascular role of relaxin was raised, when Ahokas et al8 found that the gestational decline in systolic blood pressure and decrease in vascular reactivity to angiotensin II were comparable in gravid spontaneously hypertensive rats with and without ovaries and, thus, with and without circulating relaxin. Further supportive evidence for vascular effects of relaxin was garnered by Bani-Sacchi et al,9 who reported that, in the Langendorff preparation, relaxin acutely increased coronary blood flow in rat and guinea pig hearts. This group also showed that the vasodilatory action of relaxin in the coronary circulation was prevented by …
机译:松弛素是一种6 kDa的肽激素,从卵巢的黄体中分泌出来,在怀孕期间在包括人,大鼠和小鼠在内的多种物种中在血液中循环1(有关松弛素配体和受体命名的信息,请参阅附录)。 Hisaw和同事[2,3]?他发现了这种激素,提供了第一个证据,尽管本质上是结构性的,但脉管系统是松弛素的靶标。在接受了松弛素的卵巢切除的猴子中,他们注意到子宫内膜血管内皮细胞的形态学变化与肥大和增生相一致,以及小动脉和毛细血管增大。4,5?最初报道了激素的血管舒张作用的功能证据St-Louis和Massicotte [6]的研究表明,慢性输注纯化的大鼠或猪松弛素可降低雌性自发性高血压大鼠的收缩压,但不会降低Wistar-Kyoto大鼠的收缩压。在另一项研究中,同一组研究人员显示,在开始输注后的8小时内,短期给药纯化的大鼠松弛素可降低雌性自发性高血压大鼠的平均动脉压,并且对去甲肾上腺素和精氨酸加压素的血管收缩反应减弱。 7随后,当Ahokas等[8]发现收缩压的妊娠下降和对血管紧张素II的血管反应性下降时,人们对松弛素的血管作用的生理重要性提出了一些疑问。在有和没有卵巢,因此有和没有循环松弛素的妊娠期自发性高血压大鼠中具有可比性。 Bani-Sacchi等人[9]获得了松弛素对血管作用的进一步支持证据,他报告说,在Langendorff制剂中,松弛素可急剧增加大鼠和豚鼠心脏的冠状动脉血流量。该小组还表明,松弛素在冠状动脉循环中的血管舒张作用被…抑制了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号